O'Shaughnessy Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-97
Closed -$82K 1440
2021
Q3
$82K Buy
97
+11
+13% +$11.2K ﹤0.01% 1448
2021
Q2
$109K Hold
86
﹤0.01% 1273
2021
Q1
$94K Buy
86
+49
+132% +$64.7K ﹤0.01% 1219
2020
Q4
$53K Buy
+37
New +$39.5K ﹤0.01% 1224

Other funds holding CDLX

O'Shaughnessy Asset Management's CDLX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 97 shares — an estimated $82K sold.

O'Shaughnessy Asset Management first reported a position in CDLX in Q4 2020 and held it in 4 quarters. The position peaked at $109K in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 97 Cardlytics shares in Q4 2021, an estimated $82K.
  • O'Shaughnessy Asset Management first reported a position in Cardlytics in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's Cardlytics position peaked at $109K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.